ATI Study | NIH: National Institute of Allergy and Infectious Diseases

ATI Study | NIH: National Institute of Allergy and Infectious Diseases

Analytical Treatment Interruption Study

NIAID researchers are seeking volunteers who are willing to stop taking their HIV medications for a short period of time. Understanding how the virus and immune system react to treatment interruption is an important step in creating new treatment options for those living with HIV in the future. All study participants will be closely monitored.

People who meet the following criteria may be eligible to participate:

• 18 to 65 years old
• Diagnosed with HIV after the year 2002
• CD4 (T cell) count of at least 450 cell/mm^3
• Undetectable viral load for at least 3 years

Study visits will take place at the NIH Clinical Center in Bethesda, Maryland. Participants will be compensated for their time and travel.

For more information call 1-800-411-1222 (reference ATI study 17-I-0106) or visithttps://www.niaid.nih.gov/clinical-trials/ati-study.